FDA.reportPublic FDA data

3.5 ML Repatha 120 MG/ML Cartridge

RxCUI
1801322
RxNorm name
3.5 ML Repatha 120 MG/ML Cartridge
Display name
3.5 ML Repatha 120 MG/ML Cartridge
Full name
3.5 ML Repatha 120 MG/ML Cartridge
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125522Repathaevolocumab351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cd61e902-166d-4aa6-9f3c-a18c1008d07eRepatha 420 MG in 3.5 ML Cartridge [PSN] · 3.5 ML evolocumab 120 MG/ML Cartridge [Repatha] [SBD] · 3.5 ML Repatha 120 MG/ML Cartridge [SY] · Repatha 420 MG per 3.5 ML Cartridge [SY]427These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 201520260122